Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Shortage reports
Actual shortage:
2 (2%)
Anticipated shortage:
0 (0%)
Avoided shortage:
6 (6%)
Resolved:
93 (92%)
101
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
5 (100%)
Reversed:
0 (0%)
5
0 (0%)
2 (100%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TECHNETIUM TC 99M TSC | 2MG | POWDER FOR SOLUTION KIT SOLUTION | Resolved | 2022-02-07 | 2022-02-11 | 154319 |
| TECHNETIUM TC 99M TSC | 2MG | POWDER FOR SOLUTION KIT SOLUTION | Resolved | 2022-03-10 | 2022-11-07 | 156500 |
| TECHNETIUM TC 99M TSC | 2MG | POWDER FOR SOLUTION KIT SOLUTION | Resolved | 2022-06-29 | 2022-08-27 | 163670 |
| TECHNETIUM TC 99M TSC | 2MG | POWDER FOR SOLUTION KIT SOLUTION | Resolved | 2024-01-17 | 2024-06-04 | 216303 |
| Thallous Chloride TI 201 Injection | 1 mCi/mL | Solution | Resolved | 2017-06-29 | 2017-07-04 | 14396 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Resolved | 2020-09-18 | 2020-09-21 | 124539 |
| VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2021-09-03 | 2021-09-09 | 145158 |
| VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160506 |
| VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-05-27 | 2023-01-05 | 161439 |
| VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-05-27 | 2023-01-30 | 161445 |
| VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-06-03 | 2023-02-07 | 161852 |
| VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2024-05-06 | 2024-05-18 | 227151 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2021-07-30 | 2021-08-21 | 143297 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-21 | 144296 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160510 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160513 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160516 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-31 | 160519 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-15 | 217414 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-24 | 217420 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 5 of 5